IndraLab

Statements


OTUD7B inhibits LCL161-induced invasion. 2 / 2
| 2

eidos
"Moreover , OTUD7B inhibits LCL161-induced invasion and migration by binding to and deubiquitinating TRAF3 , thereby inhibiting NIK and preventing non-canonical NF-kappaB activation ."

eidos
"However , whether OTUD7B can inhibit LCL161-induced invasion and migration and be used to select a target population in LCL161 treatment for lung cancer is unclear ."